Usefulness of the assessment of the appropriateness of left ventricular mass to detect left ventricular systolic and diastolic abnormalities in absence of echocardiographic left ventricular hypertrophy: the LIFE study
Conventional definitions of left ventricular (LV) hypertrophy do not account for interindividual differences in loading conditions. We may define LV mass as inappropriately high when exceeding 128% of theoretical values predicted by gender, height 2.7 , and stroke work, which explain up to 82% of the variability of LV mass in normal reference subjects. In 652 participants in the Losartan Intervention For Endpoint reduction in hypertension study without clinically overt cardiovascular disease or diabetes, we investigated whether inappropriately high LV mass is associated with relevant LV abnormalities independent of traditional definition of LV hypertrophy (ie, LV mass index 4116 g/m 2 in men and 4104 g/m 2 in women). The study sample was divided into three groups: patients with inappropriately high LV mass but without LV hypertrophy were compared to patients with LV hypertrophy and to patients with appropriate LV mass and without LV hypertrophy. Patients with inappropriately high but nonhypertrophic LV mass had higher body mass index and relative wall thickness, and lower LV myocardial systolic function, than patients with appropriate LV mass or patients with LV hypertrophy. In multivariate analyses, inappropriately high LV mass was independently associated with lower myocardial systolic function independent of LV hypertrophy and other covariates. Inappropriately high LV mass was also associated with prolonged isovolumic relaxation time and lower mitral E/A ratio independent of covariates. In conclusion, inappropriately high LV mass was associated with relevant, often preclinical, manifestations of cardiac disease in the absence of traditionally defined echocardiographic LV hypertrophy and concentric geometry.
Introduction
Left ventricular (LV) hypertrophy is associated with LV systolic and diastolic dysfunction, 1,2 and independently predicts cardiovascular morbidity and mortality. [3] [4] [5] Therefore, hypertensive patients without LV hypertrophy are considered at lower cardiovascular risk. However, LV systolic and diastolic dysfunction are also independent predictors of cardiovascular events. [6] [7] [8] Traditional echocardiographic criteria for LV hypertrophy rely on partition values of measured LV mass index, which usually identify the upper 2.5% of the distribution in a reference population. However, conventional diagnosis of LV hypertrophy does not account for the appropriateness of LV mass to the actual haemodynamic burden. As LV hypertrophy is in part an adaptive process to preserve pump function in the face of haemodynamic overload, taking LV workload into account permits more physiologically correct interindividual comparisons.
A previous report from our laboratory demonstrated that stroke work, gender, and ideal body size for body height explained up to 82% of the variability of LV mass in a reference population of normotensive, normal-weight subjects ranging from 6 months to 85 years of age. 9 Therefore, ideal LV mass can be estimated, 9 and the observed/predicted LV mass ratio can be used to assess whether an individual's LV mass is appropriate for loading condition, body size, and gender. In our earlier reports, inappropriately high LV mass was associated with concentric LV geometry and impaired midwall systolic mechanics in subjects with mild hypertension 10 and in more severely hypertensive patients with LV hypertrophy. 11 Moreover, more than 50% of patients with inappropriate LV mass with eccentric LV hypertrophy and preserved systolic function had prolonged LV relaxation. 11 However, it remains unclear whether significant cardiac abnormalities can be identified through the assessment of appropriateness of LV mass in hypertensive subjects without LV hypertrophy by standard criteria. A recent analysis in selected subjects with mild hypertension from southern Italy showed that inappropriately high LV mass can be associated with impaired LV midwall mechanics independently of LV hypertrophy, but did not assess LV diastolic function. 12 Proving the existence of relations of inappropriately high LV mass to LV functional abnormalities may offer a mechanism to interpret a recently reported association of inappropriate LV mass to worse prognosis in the absence of clearcut LV hypertrophy in hypertensive subjects. 13 Therefore, we evaluated participants in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study to further clarify whether prognostically relevant LV systolic and diastolic abnormalities are present in patients with moderateto-severe hypertension with inappropriately high LV mass independent to echocardiographically defined LV hypertrophy and geometry.
Methods

Population
As described previously, [14] [15] [16] between June 1995 and April 1997 patients aged 55-80 years with sitting clinic blood pressure in the range of 160-200/95-115 mmHg after 1 or 2 weeks on placebo treatment; without myocardial infarction or stroke within previous 6 months; known severe aortic stenosis or LV ejection fraction o40%; or specific requirement for treatment with a beta-blocker, angiotensin-converting enzyme inhibitor, or angiotensin receptor antagonist were recruited into LIFE if they had LV hypertrophy by electrocardiography (Cornell voltage-duration product 42440 mm Â ms, or Sokolow-Lyon voltage 438 mm).
14 Based on pilot data, the expected prevalence of echocardiographic LV hypertrophy in LIFE patients was between 62 and 78%. 15, 16 The LIFE echocardiography substudy comprised about 11% of the entire cohort of 9193 participants. 17 Of the participants in the LIFE echo substudy, 92% had measurements necessary to calculate the observed/predicted LV mass ratio. Patients with diabetes (based on physician report, self-report, or use of hypoglycaemic medication) or with clinical cardiovascular disease (self-reported angina or previous myocardial infarct/stroke, coronary revascularization, or peripheral vascular disease; 32% of the echo cohort) were excluded. Laboratory assessments included fasting glucose, HDL and total cholesterol, serum creatinine, and urinary albumin concentration expressed as a ratio to urinary creatinine concentration, as previously described. 14 
Echocardiography
A standard, reliable methodology 18 was employed in the LIFE echocardiography substudy to assess LV geometry and function. 15, 17 Echocardiograms were recorded on videotapes and centrally read at the Echo Reading Center in New York following recommendation of the American Society of Echocardiography 19 by trained physician first readers (VP, JNB) and all over-read by a highly experienced second and final arbiter (RBD). All readers were blinded to patients' clinical data. Correct orientation of echocardiographic planes and Doppler recordings was verified using standard procedures. 20 Two-dimensionally guided M-mode tracings were used, if correctly oriented, to measure LV structure, whereas linear measurements of LV structure were obtained in two-dimensional parasternal long-axis view in case of low echocardiographic window. 21 LV measurements were averaged from 2 to 5 cardiac cycles from views in which LV internal dimension was maximized in anatomically correct orientation. Enddiastolic LV dimensions were used to calculate LV mass by a formula that yields values closely related (r ¼ 0.90) to necropsy LV weight. 22 Relative wall thickness (posterior wall thickness/LV end-diastolic radius) was used to assess LV concentricity. LV enddiastolic and end-systolic volumes, derived using Teichholz et al's formula, 23 were used to calculate LV ejection fraction and stroke volume. LV hypertrophy was identified by LV mass/body surface area 4104 g/m 2 in women and 4116 g/m 2 in men. Doppler-derived stroke volume 24 was used to calculate cardiac output and total peripheral resistance by standard formulae. The observed/predicted LV mass was expressed as a percentage. A percent predicted LV mass 4128% identified inappropriately high LV mass. 9 In 158 hypertensive patients who underwent echocardiography twice during a placebo run-in, 18 the observed/predicted LV mass was found to be highly reliable (intraclass correlation coefficient ¼ 0.81). As a further test of the robustness of predicting LV mass from clinical variables and stroke volume independent of the methods of measurements, we applied an equation predicting echocardiographic LV mass from gender, height 2.7 , and Fick stroke volume to a series of normal adults studied by quantitative angiocardiography 25 and found that the predicted LV mass was very similar to angiocardiographic LV mass (167741 vs 171735 g, P ¼ NS).
Inappropriately high LV mass
LV systolic function
Ejection fraction, midwall shortening, and circumferential end-systolic stress were computed by standard methods. 6, 26 Primary noninvasive measurement of myocardial systolic function was provided by the % predicted midwall shortening as previously described, termed stress-corrected midwall shortening. 26 Low myocardial systolic function was defined as stress-corrected midwall shortening o89.2%. 27 Velocity of circumferential fibre shortening was derived at endocardial and midwall levels by dividing shortening by ejection time. 28 LV diastolic function LV diastolic filling was evaluated by pulsed Doppler, placing the sample volume at the tips of the mitral valve leaflets in the apical 4-chamber view. Peak E-and A-wave velocities and E-wave deceleration time were averaged over X3 cardiac cycles. Isovolumic relaxation time was the time from the end of transaortic flow (outflow) to the beginning of E-wave (inflow) by continuous or pulsed Doppler. 11 Abnormal LV relaxation was defined as isovolumic relaxation time 4105 ms, independent of E/A ratio, as the 95th percentile of the distribution in a reference group of normotensive, normal-weight, clinically healthy adults with similar mean age.
Statistical analysis
Data are expressed as mean7s.d. for continuous variables, or percent for categorized variables. Log transformation of continuous variables was used when needed. Analysis of variance was used to assess differences among the three groups of patients with either appropriate or inappropriate nonhypertrophied LV mass or with traditionally defined LV hypertrophy, using the Dunnett-T3 post hoc test to account for multiple comparisons and unbalanced cells. w 2 -statistic was used for categorical variables. Differences in velocity of circumferential fibre shortening were adjusted for R-R interval, circumferential end-systolic stress, gender, and age by analysis of covariance, obtaining an index of myocardial systolic performance independent of gender and age, and adjusted for pre-and afterload. 28 Differences in E/A ratio, atrial filling fraction, and isovolumic relaxation time were tested using analysis of covariance, adjusting for age, gender, and heart rate. Independent relations of inappropriate LV mass to low myocardial systolic function and to impaired LV relaxation, accounting for covariates including age, gender, SBP, heart rate, LV hypertrophy, and geometry, were evaluated by logistic and linear regression analyses, using a stepwise enter procedure (variables removed if P40.1). Two-tailed Po0.05 was considered statistically significant.
Results
Comparisons of clinical and laboratory characteristics in hypertensives with appropriate or inappropriately high LV mass vs those with LV hypertrophy
Of patients included in this study, 68% had LV hypertrophy by LV mass/body surface area criteria; they were compared to patients without LV hypertrophy (ie, LV mass in the normal range) further stratified based on appropriate or inappropriately high LV mass for loading conditions and ideal body size for body height (Table 1) . Patients with appropriate or inappropriate LV mass within the normal range were on average slightly younger than patients with LV hypertrophy. Proportion of women was minimally, and nonsignificantly, higher in patients with inappropriately high but nonhypertrophic LV mass (57%) than with appropriate LV mass (38%) or with conventionally defined LV hypertrophy (45%). Body mass index was highest in patients with inappropriately high but not hypertrophic LV mass. While diastolic blood pressure (DBP) did not differ among the three groups, SBP was highest in subjects with LV hypertrophy. Heart rate was highest in the group with inappropriately high LV mass within the normal range.
Total and HDL cholesterol and their ratio, glucose, and serum creatinine levels were similar in the three groups of patients. Urinary albumin/creatinine was higher in patients with LV hypertrophy than with either appropriate or inappropriate nonhypertrophic LV mass.
Inappropriate LV mass and ventricular dysfunction V Palmieri et al LV structure, systolic function, and haemodynamics in hypertensives with appropriate or inappropriate LV mass vs those with LV hypertrophy LV mass index showed stepwise increases from patients with normal appropriate LV mass to those with inappropriately high but nonhypertrophic LV mass to patients with LV hypertrophy (Table 2) . Relative wall thickness was highest with inappropriately high nonhypertrophic LV mass, and consequently concentric LV geometry was present in 76% of that group, 34% of those with LV hypertrophy and 29% of those with appropriate nonhypertrophic LV mass. Ejection fraction was slightly higher in patients with appropriate LV mass than in those with inappropriately high nonhypertrophic LV mass or LV hypertrophy. Circumferential end-systolic stress was lowest with inappropriately high nonhypertrophic LV mass and highest with LV hypertrophy. Midwall shortening, stress-corrected midwall shortening, and endocardial and midwall velocity of circumferential fibre shortening (as absolute values or adjusted for covariates) were lowest in the presence of inappropriate nonhypertrophic LV mass and highest with appropriate LV mass. The prevalence of low myocardial contractility was 75% in patients with inappropriately high but nonhypertrophic LV mass, vs 28% with LV hypertrophy and 9% with appropriate nonhypertrophic LV mass (Po0.001).
Doppler stroke volume was lowest with inappropriate nonhypertrophic LV mass and highest with LV hypertrophy, whereas neither cardiac output nor total peripheral resistance differed significantly among the three groups (all P ¼ NS, data not shown). similarly, E-wave deceleration time did not differ among the three groups (all P ¼ NS adjusted for age, gender, and heart rate, data not shown). In contrast, the group with appropriate nonhypertrophic LV mass had, on average, shorter isovolumic relaxation time (110723 ms) than the groups with LV hypertrophy (117723 ms, Po0.05 adjusted for age, gender, and heart rate) or with inappropriately high nonhypertrophic LV mass (119723 ms, adjusted P ¼ 0.09), although the latter comparison fell short of statistical significance.
Independent relations of inappropriate LV mass to LV systolic and diastolic abnormalities
In a multivariate logistic model, inappropriately high nonhypertrophic LV mass was associated with low stress-corrected midwall shortening (OR ¼ 51, 95% CI 24-113), independent of age, body mass index, gender, heart rate, relative wall thickness, and LV hypertrophy. This result was confirmed in a separate independent multiple regression analysis, in which the observed/predicted LV mass ratio was negatively related to midwall velocity of circumferential fibre shortening (b ¼ À0.38, Po0.001) independent of age, gender, body mass index, concentric LV geometry, and LV hypertrophy (multiple R ¼ 0.52, Po0.001).
The observed/predicted LV mass ratio was related to longer isovolumic relaxation time independent of relevant covariates including LV hypertrophy, concentric geometry, and myocardial contractility (Table 3) . In a logistic model, impaired LV relaxation (isovolumic relaxation time 4105 ms) was associated with inappropriately high LV mass (OR ¼ 2.1, 95% CI 1.2-3.2) independent of age, body mass index, heart rate, clinical SBP, gender, LV hypertrophy, concentric geometry, and low myocardial contractility. In a multiple regression analysis, the observed/predicted LV mass ratio was negatively related to the E/A ratio independent of relevant covariates (Table 3) .
Discussion
The assessment of appropriateness of LV mass for haemodynamic load introduces a new strategy to evaluate cardiac target organ damage in hypertensive patients because it allows intersubject comparison accounting for differences in loading conditions, gender, and ideal body size in a single framework. The usefulness of this approach is demonstrated by the findings in the present study, showing that in hypertensive subjects with ECG-LV hypertrophy participants in the LIFE echo substudy, myocardial systolic dysfunction and diastolic abnormalities were associated with inappropriately higher LV mass independent of the presence of LV hypertrophy, concentric LV geometry, and other relevant pathophysiologic confounders. As LV functional abnormalities independently predict cardiovascular events in hypertension, [6] [7] [8] our identification of associations between inappropriate LV mass, independent of the presence of hypertrophy, and LV dysfunction significantly extends understanding of the relation between the level of LV mass and cardiovascular events in hypertension.
Inappropriate LV mass, LV geometry, and LV function
In the present study, multivariate analyses demonstrated that inappropriately high LV mass was associated with low stress-corrected midwall shortening independent of concentric LV geometry, LV hypertrophy, and other pathophysiologic confounders, 29 which represents a significant extension of findings previously reported. 10, 12 This result is reinforced by the fact that velocity of circumferential fibre shortening was lower in presence of inappropriately high LV mass, independent of covariates.
Another important original finding of the present study is that inappropriately high LV mass was 
Inappropriate LV mass and ventricular dysfunction V Palmieri et al strongly associated with prolonged isovolumic relaxation time independent of major covariates, 30 including heart rate, blood pressure, LV hypertrophy, concentric geometry, and subnormal myocardial contractility. The associations of inappropriately high LV mass with concentric LV geometry, low myocardial systolic function, and impaired LV relaxation in the absence of LV hypertrophy suggest that inappropriately high LV mass in relation to its physiologic determinants may be a preclinical phenotype potentially predisposing to subsequent heart failure. 7 In fact, in a report from a population-based sample, concentric LV geometry and midwall dysfunction were key findings in subjects with heart failure despite normal ejection fraction. 31 Indeed, ejection fraction may be substantially normal in hypertensive patients with pulmonary oedema. 32 We have previously reported that hypertensive subjects with normal ejection fraction, but low resting midwall function had less ejection fraction increment during exercise. 33 Moreover, abnormal LV relaxation represents a common mechanism of heart failure in subjects with normal ejection fraction. 34, 35 Interestingly, stress-corrected midwall shortening is more closely related than ejection fraction to LV relaxation parameters. 2, 27, 30 In recent analyses, inappropriately high LV mass predicted cardiovascular events in hypertensives without LV hypertrophy. 13, 36 Possible stimuli for inappropriate LV mass growth Obesity is an important correlate of inappropriately high LV mass for loading conditions and ideal body size. 10, 37 This association is unmasked by the assessment of observed/predicted LV mass in part because the equation used to predict LV mass includes height 2.7 as a measure of ideal body size, 9 which does not overadjust for obesity-related increase in fat-free mass, in turn strongly related to LV mass. 38 However, stroke volume, included in the equation to predict LV mass, accounts for most of the haemodynamic impact of obesity on LV structure. 39 Therefore, the association of inappropriate LV mass with obesity is not solely explained by its haemodynamic effects. Increased blood viscosity, insulin resistance, and insulin-like growth factor-1 with obesity may be additional nonhaemodynamic stimuli to inappropriate LV mass growth. 40, 41 Moreover, the equation used to predict LV mass includes stroke work as a key component. Stroke work reflects afterload, LV chamber size, and LV chamber function. Interestingly, while ejection fraction was in the normal range in the three groups, inappropriately high LV mass was associated with reduced stress-corrected midwall shortening and midwall velocity of circumferential fibre shortening independent of LV hypertrophy and body mass index (Table 2 ). This finding may reflect increased noncontractile myocardial components associated with increased LV mass within the conventionally determined normal range. Prolonged LV relaxation was also present when LV mass within the normal range was inappropriately elevated for loading conditions and ideal body size. A genetic substrate 42 might contribute to different degrees of LV growth to preserve pump performance in the face of haemodynamic overload. However, the cross-sectional nature of our study only allows assessment of correlates of inappropriate LV mass, and cannot elucidate whether inappropriate LV mass precedes LV hypertrophy.
Inappropriate LV mass and metabolic disorders
Laboratory data differed minimally between subjects with appropriate or inappropriate LV mass, in contrast to findings in mildly hypertensive adults. 10 We should emphasize that LIFE patients are older and preselected to have electrocardiographic LV hypertrophy and moderate-to-severe hypertension, which may have led to under-representation of subjects with less adverse metabolic profiles.
Methodological considerations
Assessment of appropriateness of LV mass relies on calculation of an intrasubject reference value of LV mass to provide a comparison term for measured LV mass. Therefore, definition of inappropriate LV mass differs from traditionally defined LV hypertrophy. In fact, in the present study population of patients with moderately severe hypertension, 58% of subjects with appropriate LV mass actually had traditionally defined LV hypertrophy. As a further test of the robustness of predicting LV mass from clinical and echocardiographic variables, 9 we applied a similar methodology to a series of normal adults studied by quantitative angiocardiography 25 and found that the predicted LV mass was very similar to angiocardiographic LV mass. Therefore, assessment of appropriateness of LV mass appears suitable for use with different imaging methods and in diverse populations.
Conclusions
Inappropriate LV mass is associated with low myocardial systolic function and prolonged LV relaxation despite, on average, normal ejection fraction, and independent of LV hypertrophy and concentric geometry.
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